GRABODY

Welcome to the Brand page for “GRABODY”, which is offered here for The mark consists of the word grabody in which the y is a stylized rendering of an antibody symbol in which the light chain elements of the antibody symbol are of orange color, and in which the heavy chain elements of the antibody symbol as well as the letters g, r, a, b, o, and d are of black color.;ophthalmic preparations; ophthalmologic preparations; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; diagnostic reagents for medical or veterinary purposes; biotechnological pharmaceutical preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; antibodies being biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations acting on the central nervous system; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of parkinson's disease; anti-cancer preparations; tumor suppressing agents; immunostimulants; pharmaceutical compositions, pharmaceutical preparations for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases;the color(s) black and orange is/are claimed as a feature of the mark.;scientific research in the fields of biomedicine; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of technology for biotechnology; biotechnological research; medical research in the field of medicine; scientific research in the field of medicine; laboratory research services relating to pharmaceuticals; scientific research in the field of medicinal products; research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; pharmaceutical research and development; research on the subject of pharmaceuticals; medical and scientific research, conducting testing in the nature of clinical trials of medicines for others; medical and scientific research, conducting studies in the nature of clinical trials of medicines for others; development of cell therapy products; scientific research in the field of pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “GRABODY” is believed to be currently owned by “ABL Bio, Inc.”

Owner:
ABL BIO, INC.
Owner Details
Description:
The mark consists of the word GRABODY in which the Y is a stylized rendering of an antibody symbol in which the light chain elements of the antibody symbol are of orange color, and in which the heavy chain elements of the antibody symbol as well as the letters G, R, A, B, O, and D are of black color.;ophthalmic preparations; ophthalmologic preparations; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; diagnostic reagents for medical or veterinary purposes; biotechnological pharmaceutical preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; antibodies being biological preparations for medical purposes for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations acting on the central nervous system; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; anti-cancer preparations; tumor suppressing agents; immunostimulants; pharmaceutical compositions, pharmaceutical preparations for the treatment and prevention of cancers, neurodegenerative diseases, and infectious diseases;The color(s) Black and orange is/are claimed as a feature of the mark.;scientific research in the fields of biomedicine; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; provision of medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of technology for biotechnology; biotechnological research; medical research in the field of medicine; scientific research in the field of medicine; laboratory research services relating to pharmaceuticals; scientific research in the field of medicinal products; research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; pharmaceutical research and development; research on the subject of pharmaceuticals; medical and scientific research, conducting testing in the nature of clinical trials of medicines for others; medical and scientific research, conducting studies in the nature of clinical trials of medicines for others; development of cell therapy products; scientific research in the field of pharmaceuticals;
Categories: